Complete Revascularization in ST-Elevation Myocardial Infarction?

Between 40 and 50% of patients who present with acute ST-elevation myocardial infarction (STEMI) have multivessel coronary artery disease. 1 , 2 Joint guidelines from the American College of Cardiology, the American Heart Association, and the European Society of Cardiology recommend treatment of the...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The New England journal of medicine Ročník 376; číslo 13; s. 1282 - 1284
Hlavný autor: Køber, Lars
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Massachusetts Medical Society 30.03.2017
Predmet:
Angiography
Clinical trials
Coronary artery
Coronary vessels
Electrocardiography
Heart attacks
Heart diseases
Heart surgery
Humans
Myocardial Infarction
Myocardial Revascularization
Patients
Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction
Treatment Outcome
ISSN:0028-4793, 1533-4406, 1533-4406
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Between 40 and 50% of patients who present with acute ST-elevation myocardial infarction (STEMI) have multivessel coronary artery disease. 1 , 2 Joint guidelines from the American College of Cardiology, the American Heart Association, and the European Society of Cardiology recommend treatment of the culprit vessel only, but data from a few trials of intermediate size favor complete revascularization, mainly on the basis of reductions in the need for repeat revascularizations. 3 – 7 The severity of nonculprit vessel lesions has generally been assessed by means of angiography; in one trial, fractional flow reserve (FFR) was used. 7 Important questions therefore remain: among patients presenting . . .
Bibliografia:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMe1702825